Serial changes of apoptosis of hepatic stellate cells in acute carbon tetrachloride induced liver injury

2001 ◽  
Vol 34 ◽  
pp. 90-91
Author(s):  
K.C. Kim ◽  
K.S. Lee ◽  
Y.M. Moon ◽  
S.P. Hong ◽  
S.G. Hwang ◽  
...  
Endocrinology ◽  
2004 ◽  
Vol 145 (7) ◽  
pp. 3463-3472 ◽  
Author(s):  
Jens-Gerd Scharf ◽  
Frank Dombrowski ◽  
Ruslan Novosyadlyy ◽  
Christoph Eisenbach ◽  
Ilaria Demori ◽  
...  

Abstract Hepatic stellate cells (HSC) play a pivotal role in hepatic tissue repair and fibrogenesis. IGF-I has been considered a mitogenic signal for activation and proliferation of HSC in vitro. In the present study IGF-I and IGF-binding protein (IGFBP) gene expression was studied in a model of acute liver injury induced by a single intragastric dose of carbon tetrachloride (CCl4) in adult rats. Northern blot analysis revealed a marked increase in IGFBP-1 mRNA levels, with a maximum between 3 and 9 h after CCl4 application, whereas steady state mRNA levels of IGF-I were only moderately altered. In situ hybridization experiments demonstrated that this increase in IGFBP-1 mRNA was due to a strong expression of IGFBP-1 in the perivenous region 6–12 h after CCl4 application, extending to the midzonal region of the acinus within 24–48 h. Consequently, a prominent immunostaining for IGFBP-1 was observed in perivenous areas, with a maximum 24–48 h after intoxication. Preincubation of early cultured HSC with a nonphosphorylated IGFBP-1 from human amniotic fluid resulted in a 3.4-fold increase in IGF-I-induced DNA synthesis. The mitogenic effect of IGF-I was also potentiated when HSC were cocultivated with IGFBP-1-overexpressing BHK-21 cells compared with nontransfected cells. These data suggest that IGFBP-1 released during the early steps of liver tissue damage and repair may interact with HSC and potentiate the sensitivity of IGF-I to mitogenic signals.


2003 ◽  
Vol 39 (6) ◽  
pp. 960-966 ◽  
Author(s):  
Jung Il Lee ◽  
Kwan Sik Lee ◽  
Yong-Han Paik ◽  
Young Nyun Park ◽  
Kwang Hyub Han ◽  
...  

2021 ◽  
Author(s):  
Peng Qi ◽  
Ming-Ze Ma ◽  
Jing-Hua Kuai

Abstract Aim:To elucidate the inhibitory role of growth differentiation factor 15 (GDF15) in liver fibrosis and its possible activation mechanism in hepatic stellate cells of mice.Methods:We generated a GDF15-neutralizing antibody that can inhibit TGF-β1-induced activation of the TGF-β/Smad2/3 pathway in LX-2 cells. All the mice in this study were induced by carbon tetrachloride and thioacetamide. In addition, primary hepatic stellate cells from mice were isolated from fresh livers using Nycodenz density gradient separation. The severity and extent of liver fibrosis in mice were evaluated by Sirius Red and Masson staining. The effect of GDF15 on the activation of the TGF-β pathway was detected using dual-luciferase reporter assays and Western blotting assays.Results:The expression of GDF15 in cirrhotic liver tissue was higher than that in normal liver tissue. Blocking GDF15 with a neutralizing antibody resulted in a delay in primary hepatic stellate cell activation and remission of liver fibrosis induced by carbon tetrachloride or thioacetamide. Meanwhile, TGF-β pathway activation was partly inhibited by a GDF15-neutralizing antibody in primary hepatic stellate cells. These results indicated that GDF15 plays an important role in regulating HSC activation and liver fibrosis progression.Conclusions:The inhibition of GDF15 attenuates chemical-inducible liver fibrosis and delays hepatic stellate cell activation, and this effect is probably mainly attributed to its regulatory role in TGF-β signalling.


Hepatology ◽  
2002 ◽  
Vol 35 (1) ◽  
pp. 49-61 ◽  
Author(s):  
Yoshiya Tahashi ◽  
Koichi Matsuzaki ◽  
Masataka Date ◽  
Katsunori Yoshida ◽  
Fukiko Furukawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document